GlaxoSmithKline

GlaxoSmithKline (GSK) is in the businesses of pharmaceuticals, vaccines and consumer healthcare. GSK was formerly known as Glaxo Wellcome. The company has centres in the U.S., Belgium, China and the U.K. GSK’s products include treatments for migraines, heart failure and cancer. The company produces vaccines for hepatitis A, hepatitis B and whooping cough. GSK also has dental-care products, over-the-counter medications, nutritional drinks and smoking-cessation products.

GSK’s portfolio includes medicines in respiratory conditions and HIV. Their R&D is focused on the immune system using genetics approaches.

COVID-19

GSK is partnered with the Coalition for Epidemic Preparedness Innovations (CEPI) to use their adjuvant platform to improve immune responses to vaccines, including a collaboration with University of Queensland, Australia, which is developing a potential COVID-19 vaccine. GlaxoSmithKline (GSK) is partnering with Clover Biopharmaceuticals to provide its pandemic adjuvant system for preclinical studies with Clover’s Covid-19 S-Trimer since an adjuvant may reduce the amount of vaccine protein required.